Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992
The Effect of Exercise on Levodopa Absorption
Neurol 42:2042-2045, Carter,J.H.,et al, 1992
Apomorphine Test for Dopaminergic Response in Pts with Previously Untreated Parkinson's
Arch Neurol 49:1131-1134, Gasser,T.,et al, 1992
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992
Eosinophilia-Myalgia Syndrome Associated with Ingestion of L-Tryptophan:Muscle Biopsy Findings in 4 Patients
Neurol 41:319-321, Hollander,D.&Adelman,L.S., 1991
Does Ageing Aggravate Parkinsonisn Disability?
JNNP 54:780-782, Blin,J.,et al, 1991
Eosinophilia-Myalgia Syndrome, A Clinical Case Series of 21 Patients
Arch Int Med 151:533-537, Philen,R.M.,et al, 1991
Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991
Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991
Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991
Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991
Presynaptic Parkinsonism in Olivopontocerebellar Atrophy:Clinical, pathological, and Neurochemical Evidence
Ann Neurol 30:425-428, Pascual,J.,et al, 1991
Migraine-Related Stroke in Childhood
Lancet 337:825-826, , 1991
Neurologic Compliations of the Tryptophan-Associated Eosinophilia-Myalgia Syndrome
Arch Neurol 48:436-438, Tolander,L.M.,et al, 1991
Standard & Controlled-Release Levodopa/Carbidopa in Fluctuating Parkinson's Disease on a Protein Redistribution Diet
Arch Neurol 48:402-405, Karstaedt,P.J.,et al, 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991
Controlled-Release Delivery of L-Dopa Associated with Nonfatal Hyperthermia, Rigidity, and Autonomic Dysfunction
Neurol 41:942-943, Cunningham,M.A.,et al, 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Stereotactic Ventrolateralis Thalamotomy for Refractory Tremor in Post-Levodopa Era Parkinson's Dis
J Neurosurg 75:723-730, Fox,M.W.,et al, 1991
Stereotaxic Thalamotomy-Experiences from the Levodopa Era
JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990
Peripheral Neuropathy Associated with Eosinophilia-Myalgia Syndrome
Ann Neurol 28:522-528, Heiman-Patterson,T.D.,et al, 1990
Mononeuropathy Multiplex in Tryptophan-Associated Eosinophilia-Myalgia Syndrome
Neurol 40:1632-1633, Selwa,J.F.,et al, 1990
Clinicopath Conf
Eosinophilic Fasciitis, Case Study 4-1990, NEJM 322:252-261, 93190., , 1990
Development of Diffuse Fasciitis with Eosinophilia During L-Tryptophan Treatment:Elevated Type I Collagen Gene
Ann Int Med 112:344-351, Varga,J.,et al, 1990
L-Tryptophan-Induced Eosinophila-Myalgia Syndrome and Myopathy
Neurol 40:1629-1630, Sagman,D.L.&Melamed,J.C., 1990
Cognitive Change Following MPTP Exposure
Neurol 40:261-264, Stern,Y.,et al, 1990
The Dystonias
BMJ 300:139-144, Marsden,C.D.&Quinn,N.P., 1990
L-tryptophan and Eosinophilia-Myalgia Syndrome in New Mexico
Lancet 335:645-648, Eidson,M.,et al, 1990
Interim Guidance on the Eosinophilia-Myalgia Syndrome
Ann Int Med 112:85-87, Kilbourne,E.M.,et al, 1990
A Case of the Eosinophilia-Myalgia Syndrome Associated with Use of an L-Tryptophan
Ann Int Med 112:300-301, Flannery,M.T.,et al, 1990
Mortality Associated with Early and Late Levodopa Therapy Initiation in Parkinson's Disease
Neurol 40:265-269, Scigliano,G.,et al, 1990
Dopa-Responsive Dystonia:The Spectrum of Clinical Manifestations in a Large North American Family
Neurol 40:66-69, Nygaard,T.G.,et al, 1990
Levodopa-Induced Dyskinesia:Review, Observations, and Speculations
Neurol 40:340-345, Nutt,J.G., 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
Scleroderma, fasciitis, and Eosinophilia Associated with the Ingestion of Tryptophan
NEJM 322:874-881, 9261990., Silver,R.M.,et al, 1990
Association of the Eosinophilia-Myalgia Syndrome with the Ingestion of Tryptophan
NEJM 322:869-873, 9261990., Hertzman,P.A.,et al, 1990
Tryptophan-Induced Eosinophilia-Myalgia Syndrome
NEJM 322:926-928, Medsger,T.A., 1990
Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990
Respiratory Dysfunction Due to L-Dopa Therapy for Parkinsonism:Diagnosis Using Serial Pulmonary Function Tests
Am J Med 89:109-114, Zupnick,H.M.,et al, 1990
Two Patients with Eosinophilia Myalgia Syndrome Associated with Tryptophan
BMJ 301:21, VanGarsse,L.G.M.&Boeykens,P.P.H., 1990
Peripheral Neuropathy in the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Neurol 40 1035-1040, Smith,B.E.&Dyck,P.J., 1990
The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Ann Int Med 113:124-134, Martin,R.W.,et al, 1990
L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and Fasciitis
Medicine 69:187-199, Kaufman,L.D.,et al, 1990
Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990
Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990
Anatomy, Physiology, and Pathology of Epilepsy
lancet 336:231-232, Meldrum,B.S., 1990
Right-Left Disorientation in Dementia of the Alzheimer Type
Neurol 40:1619-1620, Fischer,P.,et al, 1990
Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease
Arch Neurol 46:1280-1283, Elizan,T.S.,et al, 1989
Swallowing Abnormalities and Their Response to Treatment in Parkinson's Disease
Neurol 39:1309-1314, Bushman,M.,et al, 1989